📢 Exciting news from #ACTG! 🌍 They've published “Pitavastatin to Prevent Cardiovascular Disease in HIV Infection” in #NEJM. The #REPRIEVE trial shows pitavastatin calcium cuts risk of cardiovascular events by 35% in HIV patients over 5 years. #IAS2023
https://t.co/jr3CtUYOql
Join the #ACTG CSS! Applications open for 2023 membership. Seeking qualified individuals from U.S. and non-US sites. Focus on Western Hemisphere for equitable representation. Apply now! #HIVresearch
Learn more here: https://t.co/QHXxezfR7w
Kneeshe Parkinson, founder of RISE Impact a motivational speaker, certified life coach, trainer, facilitator, #activist, and The Washington University AIDS Clinical Trial Unit Community Advisory Board (#CAB) member featured in the current issue of #POZ
https://t.co/dnYzOsVZn0
While U.S. health agencies watch for a potential mpox rebound this summer, here’s a brief look at how the @ACTGNetwork launched a study on mpox treatment. #clinicaltrials#mpox https://t.co/4O0ZoC15Ze
National #HIVTestingDay is June 27. No matter how you test, no matter your test results, you can take the next step for your health. Learn more about HIV testing options: https://t.co/uohkQRREnw. #StopHIVTogether
Learn what can happen when great minds come together to advance science. Our new video highlights the extraordinary efforts of Accelerating #COVID19 Therapeutic Interventions and Vaccines (ACTIV), setting a framework for future preparedness and response. https://t.co/VjP1amCWjy
Check out the new website from ACTG and experience a community-focused and user-friendly platform. #ACTG#HIVresearch#clinicaltrials#ACTG2023
https://t.co/9XIDgF41BC
Cheers to the 2023 ACTG Network Award recipients - Fredrick Sawe, Kimberly Scarsi, Rosie Mngqibisa, and Raphael Landovitz! Your exceptional dedication to #HIV#research and patient care is truly commendable. #ACTG2023
Exciting week ahead as the AIDS Clinical Trials Group 2023 meeting kicks off from June 13-16! Researchers and community members from around the world coming together to advance HIV research and treatments. Follow #ACTG2023 for updates!
#HIV#clinicaltrials#researchmatters
The #AASLD / #IDSA updated evidence-based guidance on #HCV infection diagnosis, management & treatment. From universal screening to management in unique populations, their latest update covers it all.
#HEPC#HepatitisC
Welcome to our new website! View our new anthem video and others that illustrate the scientific and human impact of our work. Learn about our commitment to using team science and patient engagement to build bridges to biomedical breakthroughs. Explore now: https://t.co/5utp6P7V54
Meet Dr. Kristine Erlandson, an Associate Professor of Medicine in the Division of Infectious Diseases at the University of Colorado. Dr. Erlandson has been actively involved in the #ACTG since she was an infectious diseases fellow. Learn more: https://t.co/SmNv8j67H9
In 2021, approximately 650,000 people died from HIV-related causes and 1.5 million people acquired HIV. Learn more facts here: https://t.co/1QEhpiYlC2
#HIVfacts#EndHIV#WHO
Meet Anne Njoroge, a CAB member for Eldoret-Kenya. She has been educating Kenyans about the importance of research, HIV prevention, and the elimination of HIV-related stigma and discrimination since 2010. Learn more here: https://t.co/SmNv8j6FwH
#eldoretkenya#CAB#EndingHIV
May 19 is National Asian & Pacific Islander HIV/AIDS Awareness Day, a day to combat stigma in Asian and Pacific Islander communities. When we reduce HIV stigma and promote prevention, testing, and treatment, we can #StopHIVTogether. https://t.co/WIthGmx2qU #NAPIHAAD#APIMay19
Today is HIV Vaccine Awareness Day, a day to recognize the volunteers, community members, and researchers working to find a safe and effective vaccine to prevent #HIV. Such a vaccine, along w/ existing HIV treatment and prevention strategies, would help to #EndHIVEpidemic. #HVAD
New research shows early self-reported adherence to #HCV treatment could help identify those at higher risk of treatment failure. Full adherence associated with higher sustained virologic response rates: https://t.co/fE6oGijnr3
#ACTG#A5360#MINMONTrial